About: http://webisa.webdatacommons.org/407527594

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The ABSORB II trial enrolled approximately 500 people, mostly in Europe, and one-year clinical results are anticipated later this year.
http://www.w3.org/ns/prov#wasQuotedFrom	prnewswire.com